Literature DB >> 8678955

Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.

J L Kraimps1, A Denizot, B Carnaille, J F Henry, C Proye, F Bacourt, E Sarfati, J L Dupond, B Maes, J P Travagli, A Boneu, P Roger, C Houdent, J Barbier, E Modigliani.   

Abstract

Primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia (MEN) type IIa is rare, occurring in 20% to 30% of the patients. The aim of this study was to evaluate clinical findings, surgical therapy, and outcome for 56 patients affected by PHPT among 249 MEN-IIa patients collected from 84 families assembled by the Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group). This retrospective study was based on cases registered by the GETC (20 participating centers) from 1969 to 1994. Characteristics of PHPT in 56 patients (31 women, 25 men) with MEN-IIa were reviewed. All but two underwent cervicotomy. The median age at diagnosis was 37.6 years. PHPT was found concomitantly with medullary thyroid carcinoma (MTC) or pheochromocytoma in 43 patients (77%). PHPT was asymptomatic in 68% of the patients. Serum calcium levels ranged from 2.20 to 3.70 mmol/L (median 2.82 mmol/L; normal 2. 10-2.60 mmol/L). The number of parathyroid glands removed at surgery was 0 (n = 2), 1 (n = 24), 2 (n = 5), > 2 (n = 12), 4 (n = 11). Pathology (initial surgery) consisted of 24 adenomas, 4 double adenomas, and 25 hyperplasia. Cure after initial surgery was obtained in 89%, including a 22% incidence of hypoparathyroidism. There were 6 cases (11%) with persistent PHPT. With a mean follow-up of 6.4 years, five patients (9%) had recurrent PHPT. The results indicate that MEN-IIa-related PHPT is generally associated with mild, often asymptomatic hypercalcemia. Despite recurrences encountered 5 to 15 years after the first cervicotomy, resection of only macroscopically enlarged glands generally appears sufficient. Subtotal or total parathyroidectomy with autotransplantation is associated with a high rate of hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678955     DOI: 10.1007/s002689900123

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Familial parathyroid tumors: diagnosis and management.

Authors:  Peter Stålberg; Tobias Carling
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

4.  First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome.

Authors:  James C Sisson; Thomas J Giordano; Victoria M Raymond; Gerard M Doherty; Stephen B Gruber
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 5.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

6.  Surgical approach to the patient with familial hyperparathyroidism.

Authors:  Lindi H VanderWalde; Philip I Haigh
Journal:  Curr Treat Options Oncol       Date:  2006-07

7.  Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe.

Authors:  Maria Alevizaki
Journal:  Thyroid Res       Date:  2013-03-14

Review 8.  Genotype-phenotype correlation in multiple endocrine neoplasia type 2.

Authors:  Friedhelm Raue; Karin Frank-Raue
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

Authors:  Louise Vølund Larsen; Delphine Mirebeau-Prunier; Tsuneo Imai; Cristina Alvarez-Escola; Kornelia Hasse-Lazar; Simona Censi; Luciana A Castroneves; Akihiro Sakurai; Minoru Kihara; Kiyomi Horiuchi; Véronique Dorine Barbu; Francoise Borson-Chazot; Anne-Paule Gimenez-Roqueplo; Pascal Pigny; Stephane Pinson; Nelson Wohllk; Charis Eng; Berna Imge Aydogan; Dhananjaya Saranath; Sarka Dvorakova; Frederic Castinetti; Attila Patocs; Damijan Bergant; Thera P Links; Mariola Peczkowska; Ana O Hoff; Caterina Mian; Trisha Dwight; Barbara Jarzab; Hartmut P H Neumann; Mercedes Robledo; Shinya Uchino; Anne Barlier; Christian Godballe; Jes Sloth Mathiesen
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.